Objective: Cystic echinococcosis (CE) is a zoonotic disease caused by Echinococcus granulosus from the cestode class. In our study, it was aimed to retrospectively evaluate the CE Indirect Hemagglutination Test (IHA) results of patients whose serum samples were sent to our laboratory between January 2020 and December 2021.

Methods: A commercial kit (Hydatidose, Fumouze laboratoires, France) is used for the diagnosis of CE in our laboratory. Demographic information, clinical findings, serology and radiology results of the patients were evaluated together.

Results: The antibody titer of 14.12% of the patients was found to be 1/320 and above. Cysts were detected in the radiology of 73 of 75 patients with positive IHA test, and CE-specific findings were reported in 58 of them. Seropositivity was found to be higher in males (14.81%) than females (13.65%). The highest percentage of positivity was in the 20-29 age group. Most of the cysts were localized in the liver (87.67%) and multi-organ cysts were detected in seven patients. Cysts were detected in the radiology of 36 of 43 patients with an antibody titer of 1/80-1/160 in IHA, and 28 of these cysts were reported to have CE-specific findings.

Conclusions: The percentage of seropositivity detected in our study was found to be compatible with the results reported from other centers in our country. The presence of cysts compatible with CE in the radiological imaging of patients with antibody titers below the threshold value suggests that it would be useful to provide these values in the final report for the diagnosis and follow-up.